v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses:        
Research and development $ 28,350 $ 19,855 $ 79,729 $ 69,191
Selling, general and administrative 21,308 16,172 59,400 47,495
Total operating expenses 49,658 36,027 139,129 116,686
Loss from operations (49,658) (36,027) (139,129) (116,686)
Other income, net:        
Interest income 4,183 1,821 9,075 6,012
Other expense, net (14) (180) (142) (1,062)
Total other income, net 4,169 1,641 8,933 4,950
Net loss $ (45,489) $ (34,386) $ (130,196) $ (111,736)
Net loss per share - basic $ (0.38) $ (0.37) $ (1.15) $ (1.25)
Net loss per share - diluted $ (0.38) $ (0.37) $ (1.15) $ (1.25)
Weighted-average shares used in computing net loss per share - basic 118,944,774 93,332,930 113,599,040 89,417,505
Weighted-average shares used in computing net loss per share - diluted 118,944,774 93,332,930 113,599,040 89,417,505